Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars
source: pixabay.com

Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars

According to a story from ankylosingspondylitisnews.com, a significant proportion of patients stopped taking a biosimilar for infliximab within six months of transitioning to the new medication. This suggests that the…

Continue Reading Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars
New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising
Source: Pixabay.com

New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising

According to a story from The Irish Times, a new campaign is encouraging people with the rare lung condition idiopathic pulmonary fibrosis to keep exercising. The campaign is centered around…

Continue Reading New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising
A Physician Sees the Patient Perspective When Getting Treated For Primary Periodic Paralysis
source: pixabay.com

A Physician Sees the Patient Perspective When Getting Treated For Primary Periodic Paralysis

According to a story from Neurology Advisor, a retired physician experienced the challenges of being a rare disease patient first hand after being diagnosed with primary periodic paralysis thanks to…

Continue Reading A Physician Sees the Patient Perspective When Getting Treated For Primary Periodic Paralysis
Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA
source: pixabay.com

Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA

According to a recent story from pm360online.com, the pharmaceutical company Shire announced that the marketing application for its drug product lanadelumab has gained approval from the European Medicines Agency (EMA).…

Continue Reading Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA
Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation
source: pixabay.com

Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation

According to a story from 4-traders.com, the pharmaceutical company SteroTherapeutics recently announced that its drug candidate ST-002 was awarded Orphan Drug Designation by the U.S. Food and Drug Administration (FDA).…

Continue Reading Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation
A New Rare Disease Podcast Amplifies Patient Voices
https://pixabay.com/en/audio-technology-mixer-volume-knob-1839162/

A New Rare Disease Podcast Amplifies Patient Voices

Rare in Common, a new monthly podcast which features stories about patients with rare diseases, made its debut on Rare Disease Day, February 28th. The podcast's goal is to raise awareness and…

Continue Reading A New Rare Disease Podcast Amplifies Patient Voices
Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
Source: Pixabay

Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials

According to a story from SMA News Today, a recent study has demonstrated that the parents of children with spinal muscular atrophy are often skeptical about enrolling their kids in…

Continue Reading Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
This Gene Could Play a Major Role in Progressive Supranuclear Palsy
source: pixabay.com

This Gene Could Play a Major Role in Progressive Supranuclear Palsy

According to a story from asianscientist.com, a group of Japanese researchers have managed to unearth a genetic mutation that is associated with progressive supranuclear palsy. The discovery is helping scientists…

Continue Reading This Gene Could Play a Major Role in Progressive Supranuclear Palsy
A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need
source: pixabay.com

A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need

An article from SRN News is reporting that a lot of people with familial hypercholesterolemia are going through life without getting the treatments that could help them, such as statins.…

Continue Reading A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need
Lower Income Patients With Anal Cancer Are More Likely to Die Compared to Wealthier Patients
Source: Pixabay

Lower Income Patients With Anal Cancer Are More Likely to Die Compared to Wealthier Patients

According to a story from cancercompass.com, a recent study has demonstrated that income level is a significant factor in determining survival for patients with anal cancer. In general, the study…

Continue Reading Lower Income Patients With Anal Cancer Are More Likely to Die Compared to Wealthier Patients